**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 13463-40-6 |Iron pentacarbonyl | | 236-670-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 37
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to respiratory system.The toxicological properties of
this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
The toxicological properties of this substance have not been fully
investigated. Causes digestive tract irritation.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Inhalation of dusts
cause severe irritation of the upper respiratory tract,
gastrointestinal disturbances, albuminuria, gradual loss of weight,
and increasing weakness.
Chronic:
Possible cancer hazard based on tests with laboratory animals. May
cause cancer according to animal studies.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at
least 15 minutes while removing contaminated clothing and shoes. Wash
clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing,
give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Substance
is noncombustible. Vapors may be heavier than air. They can spread
along the ground and collect in low or confined areas.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Keep container tightly closed. Avoid
ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR
1910.134 or European Standard EN 149. Always use a
NIOSH or European Standard EN 149 approved respirator
when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Appearance: white
Odor: odorless
pH: Neutral
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 2500 deg C
Freezing/Melting Point: 1830 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water: Insoluble in water.
Specific Gravity/Density: 4.1700
Molecular Formula: TiO2
Molecular Weight: 79.8788
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, titanium/titanium oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 13463-40-6: NO4900000
LD50/LC50:
CAS# 13463-40-6: Inhalation, mouse: LC50 = 2190 mg/m3/30M;
Inhalation, rat: LC50 = 10 ppm/4H; Oral, mouse: LD50 = 62 mg/kg;
Oral, rabbit: LD50 = 12 mg/kg; Oral, rat: LD50 = 25 mg/kg; Skin,
rabbit: LD50 = 56 mg/kg.
Carcinogenicity:
Iron pentacarbonyl -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 37 Irritating to respiratory system.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 13463-40-6: No information available.
United Kingdom Occupational Exposure Limits
CAS# 13463-40-6: OES-United Kingdom, TWA as Fe: 0.01 ppm TWA; 0.08
mg/m3 TWA
CAS# 13463-40-6: OES-United Kingdom, STEL (listed as ** undefined
**): as Fe: 2 mg/m3 STEL
Canada
CAS# 13463-40-6 is listed on Canada's DSL List.
CAS# 13463-40-6 is listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 13463-40-6: OEL-AUSTRALIA:TWA 0.1 ppm (0.8 mg/m3);STEL 0.2 ppm (1
.6 mg/m3)
OEL-BELGIUM:TWA 0.1 ppm (0.23 mg/m3);STEL 0.2 ppm (0.45 mg/m3)
OEL-DENMARK:TWA 0.1 ppm (0.8 mg/m3)
OEL-FINLAND:STEL 0.01 ppm (0.08 mg/m3)
OEL-FRANCE:TWA 0.1 ppm (0.8 mg/m3)
OEL-GERMANY:TWA 0.1 ppm (0.8 mg/m3)
OEL-THE NETHERLANDS:TWA 0.01 ppm (0.08 mg/m3)
OEL-RUSSIA:STEL 0.1 mg/m3;Skin
OEL-SWITZERLAND:TWA 0.1 ppm (0.8 mg/m3);STEL 0.2 ppm (1.6 mg/m3)
OEL-UNITED KINGDOM:TWA 0.01 ppm (0.08 mg/m3) JAN9
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 13463-40-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 10/15/1998 Revision #2 Date: 8/02/2000
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Aminonicotinic Acid, 98%
| 3167-49-5 |
|
Rhodamine 6g Perchlorate, Laser Grade, 99% (TLC)
| 13161-28-9 |
|
3-Thiophenemalonic acid, 98+%
| 21080-92-2 |
|
Poly(Sodium-P-Styrenesulfonate), Average M.W.100.000
| 25704-18-1 |
|
3-Cyclohexylpropionaldehyde, 99%
| 4361-28-8 |
|
Tripropylamine, 99+%
| 102-69-2 |
|
1,10-Decanediol, 95% (GC)
| 112-47-0 |
|
Cyclooctanol, 99%
| 696-71-9 |
|
l-(-)-Sorbose, 99%
| 87-79-6 |
|
6-Bromo-2-Naphthyl-Beta-D-Glucopyranoside
| 15548-61-5 |
|
1-Hexadecylsulfonic acid, sodium salt, HPLC grade
| 15015-81-3 |
|
3-Carbethoxy-4-Piperidone Hydrochloride 98% (TLC)
| 4644-61-5 |
|
1,3-Dimethylurea, 98%
| 96-31-1 |
|
Diethyl 1,4-Dihydro-2,4,6-Trimethyl- 3,5-Pyridinedicarboxylate, 99%
| 632-93-9 |
|
Dimethylthiocarbamoyl Chloride, 99% (Titr.)
| 16420-13-6 |
|
3,3',5,5'-Tetramethylbenzidine, 99+%
| 54827-17-7 |
|
3,5-Diamino-1,2,4-Triazole 98%
| 1455-77-2 |
|
2-(Trifluoromethyl)benzimidazole
| 312-73-2 |
|
(1R,2R)-(+)-1,2-Diphenyl-1,2-Ethane Diamine, 99% (99% e.e.)
| 29841-69-8 |
|
1-Methyl-7-Hydroxy-6-Methoxy-3,4-Dihydroisoquinoline, 99+%
| 4602-70-4 |
|
Amberlite IRC-50 Ion-Exchange Resin
| 9002-29-3 |
|
Tetrahexylammonium Iodide, 99% (Titr.)
| 2138-24-1 |
|
L(-)-methanesulfonylethyllactate
| 63696-99-1 |
|
Tetrafluoroterephthalonitrile, 97%
| 1835-49-0 |
|
2-Furoic acid hydrazide, 98%
| 3326-71-4 |
|
4-Cyclohexylaniline, 97%
| 6373-50-8 |
|
8-Formyl-7-methoxy-1,4-dioxa-8-azaspiro[4.5]decane, tech., 85%
| |
|
(2-Hydroxybenzoyl)methylenetriphenylphosphorane, 98%
| 0-01-1 |
|
3-Acetyl-1-propanol, 96%
| 1071-73-4 |
|
4-Chlorobenzotrifluoride, 98%
| 98-56-6 |
|
p-Tolyl Isothiocyanate, 99%
| 622-59-3 |
|
Boron trifluoride - acetic acid complex, c a. 33% bf3
| 373-61-5 |
|
Titanium (IV) Oxide, 98.0 - 100.5% TiO2
| 13463-40-6 |
|
Ethylmercurithiosalicylic acid, sodium salt
| 54-64-8 |
|
1-Iodopentane, 97% (GC)
| 628-17-1 |
|
(4-Carboxybutyl)triphenylphosphonium bromide, 98%
| 17814-85-6 |
|
Dichloroacetyl Chloride, 97%
| 79-36-7 |
|
trans-Traumatic acid, 97%
| 6402-36-4 |
|
1,4-Pentadiene, 99%
| 591-93-5 |
|
2-Chloro-p-phenylenediamine dihydrochloride, 99% (uv-vis)
| 615-46-3 |
|
Calcium 2-ethylhexanoate
| 136-51-6 |
|
N-Hydroxysuccinimide, 98+%
| 6066-82-6 |
|
2,2-Diphenylpropylamine Hydrochloride, 95%
| 40691-66-5 |
|
Cerium atomic absorption standard solution 1 mg/ml Ce in 2% HNO3
| 7440-45-1 |
|
alpha-Pyridoin, 99%
| 1141-06-6 |
|
4,6-Dimethyl-2-Pyrone, 98%
| 675-09-2 |
|
Oleic acid, sodium salt, 65-90% oleic C18
| 143-19-1 |
|
(+/-)-Tetrahydropapaveroline Hydrobromide, 98%
| 4747-99-3 |
|
5-Bromo-2-fluorotoluene, 99%
| 51437-00-4 |
|
2-Methoxy-4-Methylphenol, 99% (GC)
| 93-51-6 |
|
|